Skip to main content
. 2023 Jan 31;3(2):276–292. doi: 10.1021/jacsau.2c00532

Figure 2.

Figure 2

General mechanism of β-lactamase inhibitors. (A) Acylation of serine-β-lactamases (Ser-BLs) by tazobactam to form an ester linkage. (B) Reversible acylation of Ser-BLs by avibactam to form a carbamoyl linkage. (C) Bisthiazolidines bind to the dizinc centers of metallo-β-lactamases (MBLs) via a free thiol group. (D) Boronic acid inhibitors form tetrahedral intermediates with β-lactamases.